| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/RHEUMATOLOGY/34.9.866 |
| P953 | full work available at URL | http://academic.oup.com/rheumatology/article-pdf/34/9/866/5019410/34-9-866.pdf |
| P698 | PubMed publication ID | 7582729 |
| P5875 | ResearchGate publication ID | 15615864 |
| P50 | author | David A. Isenberg | Q42326409 |
| P2093 | author name string | L. B. Tucker | |
| S. Menon | |||
| J. G. Schaller | |||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | systemic lupus erythematosus | Q1485 |
| lupus erythematosus | Q188297 | ||
| serology | Q502159 | ||
| P304 | page(s) | 866-872 | |
| P577 | publication date | 1995-09-01 | |
| P1433 | published in | British Journal of Rheumatology | Q27709787 |
| P1476 | title | Adult- and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome | |
| P478 | volume | 34 |
| Q55317432 | 13-year-old Girl with Fevers. |
| Q35194978 | 17β-Estradiol protects against the progression of hypertension during adulthood in a mouse model of systemic lupus erythematosus |
| Q33759553 | A review of gastrointestinal manifestations of systemic lupus erythematosus. |
| Q35638742 | Abdominal manifestations in childhood-onset systemic lupus erythematosus. |
| Q41964629 | Acute epiglottitis as the initial presentation of pediatric Systemic Lupus Erythematosus |
| Q37845009 | Acute pancreatitis in pediatric and adult-onset systemic lupus erythematosus: a comparison and review of the literature |
| Q33635924 | Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case-control study within LUMINA, a multiethnic US cohort (LUMINA LVII) |
| Q27690838 | Adult outcomes of childhood-onset rheumatic diseases |
| Q48795517 | Altered Blood-Brain Barrier Permeability in Patients With Systemic Lupus Erythematosus: A Novel Imaging Approach. |
| Q44003262 | Alveolar hemorrhage: distinct features of juvenile and adult onset systemic lupus erythematosus |
| Q46076323 | Anti-CD20 monoclonal antibody in acute life threatening haemolytic anaemia complicating childhood onset SLE. |
| Q37798192 | Approach to a patient with connective tissue disease |
| Q35553302 | Association of the oestrogen receptor alpha gene polymorphisms with disease onset in systemic lupus erythematosus |
| Q28082493 | Biomarkers for CNS involvement in pediatric lupus |
| Q35810911 | Biomarkers for kidney involvement in pediatric lupus |
| Q33961468 | Can estrogens promote hypertension during systemic lupus erythematosus? |
| Q37689969 | Cancer risk in childhood-onset systemic lupus |
| Q47837405 | Cardio-pulmonary involvement in juvenile systemic lupus erythematosus |
| Q39043287 | Challenges of Diagnosing Cognitive Dysfunction With Neuropsychiatric Systemic Lupus Erythematosus in Childhood. |
| Q38237868 | Chance, genetics, and the heterogeneity of disease and pathogenesis in systemic lupus erythematosus |
| Q57467570 | Child-onset systemic lupus erythematosus is associated with a higher incidence of myopericardial manifestations compared to adult-onset disease |
| Q33379920 | Childhood systemic lupus erythematosus in Latin America. The GLADEL experience in 230 children. |
| Q39067278 | Childhood versus adult-onset systemic lupus erythematosus: long-term outcome and predictors of mortality. |
| Q37754678 | Childhood- and adult-onset lupus: an update of similarities and differences. |
| Q40632136 | Childhood-onset Systemic Lupus Erythematosus: clinical presentation and prognosis in 31 patients |
| Q37127464 | Childhood-onset disease as a predictor of mortality in an adult cohort of patients with systemic lupus erythematosus |
| Q40443107 | Childhood-onset systemic lupus erythematosus. |
| Q51196776 | Children and adolescents with SLE: not just little adults. |
| Q33755568 | Chinese Systemic Lupus Erythematosus Treatment and Research Group Registry IX: Clinical Features and Survival of Childhood-Onset Systemic Lupus Erythematosus in China |
| Q44784932 | Clinical and immunological profile of systemic lupus erythematosus |
| Q35743904 | Clinical and serological manifestations associated with interferon-α levels in childhood-onset systemic lupus erythematosus |
| Q64269240 | Clinical characteristics of males with systemic lupus erythematosus (SLE) in an inception cohort of patients in Ghana |
| Q50285114 | Clinical predictors of proteinuric remission following an LN flare - evidence from the UK JSLE cohort study |
| Q53470732 | Clinical, laboratory and neuroimage findings in juvenile systemic lupus erythematosus presenting involvement of the nervous system. |
| Q51776721 | Clinicopathological correlations of paediatric lupus nephritis. |
| Q46586943 | Clinicopathology of childhood-onset renal systemic lupus erythematosus |
| Q35893809 | Cognitive Performance Scores for the Pediatric Automated Neuropsychological Assessment Metrics in Childhood-Onset Systemic Lupus Erythematosus |
| Q41540102 | Consensus of the Brazilian Society of Rheumatology for the diagnosis, management and treatment of lupus nephritis |
| Q37726019 | Conservation of pathogenic TCR homology across class II restrictions in anti-ribonucleoprotein autoimmunity: extended efficacy of T cell vaccine therapy. |
| Q33813399 | Contraception for adolescents with lupus. |
| Q36915649 | Contraception in adolescents with systemic lupus erythematosus |
| Q44380435 | Coronary artery dilation among patients with paediatric-onset systemic lupus erythematosus |
| Q35551569 | Critical illness in systemic lupus erythematosus and the antiphospholipid syndrome |
| Q36908996 | Current issues in pediatric lupus nephritis: role of revised histopathological classification |
| Q35680302 | Damage index in childhood-onset systemic lupus erythematosus in Egypt. |
| Q38763655 | Delays to care in pediatric lupus patients from the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry |
| Q40038921 | Differences in clinical features observed between childhood-onset versus adult-onset systemic lupus erythematosus: A systematic review and meta-analysis |
| Q33397369 | Differences in clinical manifestations between childhood-onset lupus and adult-onset lupus: a meta-analysis |
| Q33431990 | Differences in disease phenotype and severity in SLE across age groups |
| Q33871944 | Differences in long-term disease activity and treatment of adult patients with childhood- and adult-onset systemic lupus erythematosus |
| Q36123351 | Differential manifestations of prepubescent, pubescent and postpubescent pediatric patients with systemic lupus erythematosus: A retrospective study of 96 Chinese children and adolescents. |
| Q45812853 | Disease activity, severity, and damage in the UK Juvenile-Onset Systemic Lupus Erythematosus Cohort |
| Q24234659 | Disease modifying immunosuppressant drugs for juvenile-onset systemic lupus erythematosus |
| Q46553014 | Disease outcomes and ovarian function of childhood-onset systemic lupus erythematosus |
| Q33376311 | Distinctive clinical features of pediatric systemic lupus erythematosus in three different age classes |
| Q33750407 | Diversity in presenting manifestations of systemic lupus erythematosus in children |
| Q35082426 | End-stage renal disease due to lupus nephritis among children in the US, 1995-2006. |
| Q53311588 | Enteric-coated mycophenolate sodium in pediatric lupus nephritis: a retrospective cohort study. |
| Q33366672 | Epidemiology treatment and outcome of childhood systemic lupus erythematosus in Egypt |
| Q35162962 | Estrogen in cardiovascular disease during systemic lupus erythematosus |
| Q43752384 | European ancestry decreases the risk of early onset, severe lupus nephritis in a single center, multiethnic pediatric lupus inception cohort |
| Q35764528 | Extent of subclinical pulmonary involvement in childhood onset systemic lupus erythematosus in the sultanate of oman. |
| Q55112474 | Final adult height of patients with childhood-onset systemic lupus erythematosus: a cross sectional analysis. |
| Q48695732 | Gastrointestinal system manifestations in juvenile systemic lupus erythematosus. |
| Q37585137 | Gender and age influence on clinical and laboratory features in Chinese patients with systemic lupus erythematosus: 1,790 cases |
| Q47422803 | Gene expression of cytokines (TNF-α, IFN-γ), serum profiles of IL-17 and IL-23 in paediatric systemic lupus erythematosus |
| Q47383976 | High Health Care Utilization Preceding Diagnosis of Systemic Lupus Erythematosus in Youth. |
| Q35225827 | High prevalence of myositis in a southeastern United States pediatric systemic lupus erythematosus cohort. |
| Q40940930 | Immunological and clinical differences between juvenile and adult onset of systemic lupus erythematosus |
| Q34356411 | Impact of early life ovariectomy on blood pressure and body composition in a female mouse model of systemic lupus erythematosus |
| Q51151220 | Incidence and prognosis of systemic lupus erythematosus in a 35 year period in Fukushima, Japan. |
| Q46602225 | Induction therapy with low-dose intravenous cyclophosphamide, oral mizoribine, and steroids for severe lupus nephritis in children |
| Q42911786 | Interest of mycophenolate mofetil in children with membranous lupus nephritis |
| Q57578997 | Interleukin-4 single nucleotide polymorphisms in juvenile systemic lupus erythematosus |
| Q37547407 | International validation of a urinary biomarker panel for identification of active lupus nephritis in children |
| Q37298723 | Intravenous cyclophosphamide combined with steroids in pediatric onset severe lupus nephritis |
| Q45129675 | Intravenous cyclophosphamide for lupus nephritis in Thai children |
| Q44593708 | Juvenile and adult-onset systemic lupus erythematosus: an ethnicity-based comparison. |
| Q40505162 | Juvenile systemic lupus erythematosus in Nigeria |
| Q38854545 | Juvenile systemic lupus erythematosus: onset patterns and short-term outcome in Egyptian children, a single-center experience |
| Q26849746 | Juvenile systemic lupus erythematosus: review of clinical features and management |
| Q54175860 | Lack of association between interleukin-10, transforming growth factor-beta gene polymorphisms and juvenile-onset systemic lupus erythematosus. |
| Q61831377 | Le lupus érythémateux disséminé de l'enfant |
| Q64109131 | Living with systemic lupus erythematosus in South Africa: a bitter pill to swallow |
| Q36915654 | Lupus in adolescence. |
| Q63323540 | Lupus nephritis in Chinese children – a territory-wide cohort study in Hong Kong |
| Q38992283 | Lupus nephritis in Egyptian children: a 16-year experience. |
| Q37866302 | Lupus nephritis in Iranian children: a review of 60 patients |
| Q51350730 | Lupus nephritis is more severe in children and adolescents than in older adults. |
| Q61831347 | Lupus érythémateux systémique |
| Q38002833 | Male versus female lupus: a comparison of ethnicity, clinical features, serology and outcome over a 30 year period |
| Q35361496 | Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics |
| Q44436037 | Markers of acute neuropsychiatric systemic lupus erythematosus: a multidisciplinary evaluation |
| Q34294355 | Meta-analysis of associations of IL1 receptor antagonist and estrogen receptor gene polymorphisms with systemic lupus erythematosus susceptibility |
| Q33829687 | Meta-analysis of programmed cell death 1 polymorphisms with systemic lupus erythematosus risk |
| Q34937950 | Mucocutaneous manifestations in juvenile-onset systemic lupus erythematosus: a review of literature |
| Q89947833 | No association of complement mannose-binding lectin deficiency with cardiovascular disease in patients with Systemic Lupus Erythematosus |
| Q35551526 | Outcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades |
| Q37800298 | Pediatric lupus in Asia |
| Q38102946 | Pediatric lupus nephritis: more options, more chances? |
| Q33723511 | Pediatric lupus--are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus? |
| Q40697721 | Pediatric onset systemic lupus erythematosus: about a case |
| Q36903365 | Plasma levels of osteopontin identify patients at risk for organ damage in systemic lupus erythematosus |
| Q84594208 | Predictors for neuropsychiatric development in Chinese adolescents with systemic lupus erythematosus |
| Q47292875 | Predictors of disability in a childhood-onset systemic lupus erythematosus cohort: results from the CARRA Legacy Registry |
| Q35738664 | Predictors of kidney disease in a cohort of pediatric patients with lupus |
| Q37777642 | Prevalence and burden of pediatric-onset systemic lupus erythematosus |
| Q47788785 | Prevalence and features of metabolic syndrome in childhood-onset systemic lupus erythematosus. |
| Q36587996 | Prevalence, incidence, and demographics of systemic lupus erythematosus and lupus nephritis from 2000 to 2004 among children in the US Medicaid beneficiary population |
| Q50984321 | Pulse cyclophosphamide induction treatment in Thai children with diffuse proliferative lupus nephritis. |
| Q53242137 | Renal damage in systemic lupus erythematosus: a comparative analysis of different age groups. |
| Q81205678 | Renal tubular dysfunction in children with systemic lupus erythematosus |
| Q35858533 | Retrospective study of plasma exchange in children with systemic lupus erythematosus |
| Q33341018 | Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage |
| Q37272264 | Safety and Efficacy of Belimumab to Treat Systemic Lupus Erythematosus in Academic Clinical Practices |
| Q35666611 | Serum interleukin-17 levels are associated with nephritis in childhood-onset systemic lupus erythematosus |
| Q33380947 | Severe clinical course of systemic lupus erythematosus in the first year of life |
| Q51813171 | Short-term outcomes of severe lupus nephritis in a cohort of predominantly African-American children. |
| Q39246970 | Signal transducer and activator of transcription 5 is implicated in disease activity in adult and juvenile onset systemic lupus erythematosus. |
| Q41680587 | Similarities and differences between pediatric and adult patients with systemic lupus erythematosus |
| Q50885213 | Survival analysis of 306 European Spanish patients with systemic lupus erythematosus. |
| Q43468721 | Survival rates and risk factors for mortality in systemic lupus erythematosus patients in a Chinese center |
| Q35548094 | Systemic lupus erythematosus (SLE) in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults |
| Q40440734 | Systemic lupus erythematosus and infections: a retrospective study in Saudis |
| Q33363090 | Systemic lupus erythematosus in Kuwaiti children: organ system involvement and serological findings |
| Q78374010 | Systemic lupus erythematosus in childhood |
| Q41944292 | Systemic lupus erythematosus in children and adolescents |
| Q46430510 | Systemic lupus erythematosus in three ethnic groups: III. A comparison of characteristics early in the natural history of the LUMINA cohort. LUpus in MInority populations: NAture vs. Nurture |
| Q32175831 | Systemic lupus erythematosus. Disease outcome in patients with a disease duration of at least 10 years: second evaluation |
| Q36295937 | Taxonomy for systemic lupus erythematosus with onset before adulthood |
| Q90159347 | Temporal Hemodynamic Changes in a Female Mouse Model of Systemic Lupus Erythematosus |
| Q36915684 | The Paediatric Rheumatology International Trials Organization (PRINTO). |
| Q36577380 | The management of pediatric systemic lupus erythematosus |
| Q40188124 | The national incidence and clinical picture of SLE in children in Australia - a report from the Australian Paediatric Surveillance Unit |
| Q38130647 | The outcome of patients with renal involvement in pediatric-onset systemic lupus erythematosus--a 20-year experience in Asia. |
| Q30596968 | The pathogenesis, diagnosis and treatment of lupus nephritis |
| Q37113440 | Therapy Insight: cardiovascular disease in pediatric systemic lupus erythematosus |
| Q33357591 | Thrombocytopenia and thromboembolism in pediatric systemic lupus erythematosus |
| Q35019423 | Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006. |
| Q38777852 | Understanding mechanisms of hypertension in systemic lupus erythematosus |
| Q46605378 | Urinary N-acetyl-beta-D-glucosaminidase (NAG) in lupus nephritis and rheumatoid arthritis. |
| Q38010347 | Urine biomarkers in juvenile-onset SLE nephritis |
| Q48538849 | Use of single photon emission computed tomography and magnetic resonance to evaluate central nervous system involvement in patients with juvenile systemic lupus erythematosus |
| Q51809852 | Variability and correlates of high sensitivity C-reactive protein in systemic lupus erythematosus. |
| Q38591752 | Why are kids with lupus at an increased risk of cardiovascular disease? |
| Q51490837 | Worse renal outcome of lupus nephritis in male patients: a case-control study. |
| Q81575727 | [Early diagnosis in patients with systemic lupus erythematosus (SLE)] |
| Q80800852 | [The presentation of childhood systemic lupus erythematosus with neurological symptoms: three-case reports] |
| Q73338674 | [Treatment of lupus nephritis in children] |
Search more.